SBIR-STTR Award

MEMS Biosensor for In Situ Drinking Water Analysis
Award last edited on: 3/23/02

Sponsored Program
SBIR
Awarding Agency
EPA
Total Award Amount
$295,000
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Noe A Salazar

Company Information

JCP Technologies Inc

11613 124TH Avenue NE Suite G535
Kirkland, WA 98034
   (572) 671-1369
   N/A
   N/A
Location: Single
Congr. District: 01
County: King

Phase I

Contract Number: 68D99052
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1999
Phase I Amount
$70,000
The use of nucleic acid-based detection technologies provides the greatest potential for highly specific and sensitive detection of pathogens in drinking water systems. These technologies are driving the development of miniature, highly portable biosensors. The most promising approach to developing the ideal biosensor is microfabrication of identification systems that mimic diagnostic schemes used in microbiology laboratories. Although there is much activity in this area, most efforts suffer from the inability to properly marry microfabrication technology with the molecular biology required for sensitive and specific detection. To eliminate these shortcomings, JCP Technologies proposes to: (1) develop an assay that takes advantage of DNA probe specificity with increased sensitivity through coupled branch DNA ( DNA) signal amplification, and (2) design the microfluidic system necessary to perform the assay on a microfabricated silicon chip. Accomplishment of these objectives will allow development of microelectromechanical system-based biosensors for specific detection and identification of microbial pathogens in drinking water.Microfabrication techniques, although initially expensive to develop, hold the promise for being cheap to manufacture in mass quantities. By using DNA probes for bacterial targets of commercial interest, low-cost, portable diagnostic equipment will be developed. Significant markets for such biosensors include food processing, veterinary, agricultural, environmental, industrial, and clinical markets. Other beneficiaries of these systems will be the EPA and other government inspection agencies, including the Food and Drug Administration.Supplemental

Keywords:
small business, SBIR, monitoring, engineering

Phase II

Contract Number: 68D01063
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
2001
Phase II Amount
$225,000
The occurrence of causative agents such as Cryptosporidium parvum and other pathogens in water supplies presents a critical issue. Transmitted through water and animals, these organisms provide a reservoir of infection, which results in the excretion of the environmentally stable cysts or oocysts that are impervious to inactivation by many drinking water disinfectants. Cryptosporidium infections are particularly problematic for immuno-compromised individuals because drug therapy to control or eliminate this organism from a human host is not yet available. The method currently used for detection of these pathogenic microorganisms at the water source is not only laborious and time consuming, but often inefficient in accurately recovering and identifying waterborne pathogens. Various alternative technologies have been investigated; however, none to date have been able to provide the possibility of rapid, sensitive, and low-cost field testing. The use of nucleic acid based detection technologies, such as DNA probes, provides the greatest potential for highly specific and sensitive detection of potentially hazardous biological agents. The most promising approach to developing the ideal biosensor is microfabrication of identification systems that mimic diagnostic schemes utilized in microbiology laboratories to detect and identify specific microbial agents. Although there is much activity in this area, most efforts suffer from the inability to properly marry microfabrication technology with the molecular biology required for sensitive and specific detection. In completing the Phase I program, JCP Technologies has successfully: (1) developed an assay that takes advantage of DNA probe specificity with increased sensitivity through coupled branch DNA (bDNA) signal amplification, (2) designed the microfluidic system necessary to perform the assay on an integrated miniaturized instrument, and (3) demonstrated the microfabricated components for the system. In this Phase II, JCP Technologies will proceed to integrate the assay with microfluidics and MEMS components to develop a compact and portable biosensor for specific detection and identification of Cryptosporidium and other microbial pathogens in drinking water. Supplemental

Keywords:
small business, SBIR, Cryptosporidium, microbial pathogens, drinking water, analytical, monitoring, microfluidics, DNA probe, EPA.